ECHA states REACH-IT and Helpdesk availability at year end
11-25-2009: ECHA will use the Christmas break for a major upgrading of the REACH-IT submission system, which will be closed from the lunchtime of 14 December 2009 to 3 January 2010 inclusive. The Helpdesk and ECHA’s offices will be closed from 24 December to 3 January inclusive. By lunchtime of 4 January 2010, REACH-IT will re-open and be available for submissions 24 hours a day during the working week – from 8.00 Monday
until 19.00 Friday
Dossier submission via REACH-IT needs to be temporarily suspended over the Christmas break to allow ECHA to migrate to a new version of the REACH-IT software. A similar suspension was also executed last year. This new version is an essential part of the ongoing programme to enhance the performance of the software to sustain the extraordinary volumev of registrations expected in 2010. The changes will also ‘pave the way’ for further releases of REACH-IT during Q1 2010 which will provide new industry functionalities, including the ‘Legal entity change’ module and C&L bulk notification submission module.
Because this software release involves a significant change in REACH-IT technical implementation, a full migration of the entire REACH-IT database is required and dossier submissions need to be suspended. Before being able to perform the migration, all previously submitted dossiers must have been fully processed (ie. undergone the business rule check, invoicing and technical completeness check). Therefore, dossier submission will be closed from 13:00 EET on Monday 14 December so that ECHA can ensure that all dossiers are fully processed in order to allow the migration to be carried out.
REACH-IT continues to be available until 18 December for companies to sign-up, search, view and retrieve information on pre-registrations and registrations and to claim the registration numbers for “new” substances they notified before 1 June 2008 under the previous legislation. Migration will start on 21 December, which requires a full closure of all REACH-IT functionalities.
Contact / Request information
Request further information free of charge:
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2SCHOTT Instruments has changed its name to SI Analytics
- 3VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
- 4SGS Minerals Services opens new lab in Chennai, India
- 5MDS Sciex Opens Manufacturing Facility in Singapore
- 6Sartorius opens new plant in India
- 7Affymetrix and eBioscience Amend Definitive Merger Agreement
- 8Fluidigm China Opens Its Doors
- 9Thermo Fisher Scientific Acquires NanoDrop Technologies
- 10PIAB announces new Chief Executive Officer
- AB SCIEX Achieves ISO 13485 Certification for Manufacturing of LC/MS Systems
- ECHA launches a new public consultation on proposals for harmonised classifi ...
- Beckman Coulter, Inc. Obtains CLIA Certificate, Licensure for Clinical Seque ...
- Substance evaluation starts under REACH: The first list of substances published
- MDxHealth Receives CLIA Certification and California State License for its ...
- ECHA launches a new public consultation on proposals for harmonised classification and labelling for four pesticides and a fire-preventing agent
- Substance evaluation starts under REACH: The first list of substances published
- Genetic regulation of metabolomic biomarkers - paths to cardiovascular diseases and type 2 diabetes
- Biochemical signature predicts progression to Alzheimer’s disease
- VTT examined the first bottle of beer from Åland shipwreck
- UCLA researchers create 'fly paper' to capture circulating cancer cells - - New method may help improve diagnosis, prognosis and treatment monitoring
- FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets - - Experts to Re-examine Guidance for Platelet Testing
- Joint efforts to control diseases transmitted from animals to humans - - BfR Symposium on Zoonoses and Food Safety
- New Light On Electron Density - - Measuring electron orbitals
- Lab901 and Biofortuna to collaborate on automated PCR Dx for HLA and Coeliac disease -





